Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress

Biogen (NASDAQ: BIIB) December weekly option implied volatility is at 55, December is at 51; compared to its 52-week range of 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.

You May Also Be Interested In

• Market Vectors Oil Services ETF (OIH) call put ratio 1.4 calls to 1 put as oil pulls back
• Intel (INTC) call put ratio 1.6 calls to 1 put amid rally
• ExxonMobil (XOM) call put ratio 1.4 calls 1 put as oil prices pull back